tiprankstipranks
Noronex Ltd. (AU:NRX)
ASX:NRX
Australian Market
Want to see AU:NRX full AI Analyst Report?

Noronex Ltd. (NRX) AI Stock Analysis

6 Followers

Top Page

AU:NRX

Noronex Ltd.

(Sydney:NRX)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
AU$0.01
▲(10.00% Upside)
Action:Reiterated
Date:06/19/26
The score is primarily held down by weak financial performance (large losses and sustained cash burn) and a technically weak longer-term trend. Valuation provides limited support because the negative P/E reflects loss-making operations and no dividend yield is available.
Positive Factors
Debt-free Balance Sheet
A debt-free balance sheet materially lowers financial risk and interest burdens, giving management flexibility to prioritize exploration or project development without fixed debt servicing. Over 2–6 months this improves resilience to commodity cycles and reduces immediate refinancing pressure.
Negative Factors
Persistent Cash Burn
Sustained negative operating and free cash flow forces ongoing reliance on external financing to fund operations and exploration. Over several months this elevates funding risk, can delay projects, and increases probability of dilutive capital raises that compress existing equity value.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free Balance Sheet
A debt-free balance sheet materially lowers financial risk and interest burdens, giving management flexibility to prioritize exploration or project development without fixed debt servicing. Over 2–6 months this improves resilience to commodity cycles and reduces immediate refinancing pressure.
Read all positive factors

Noronex Ltd. (NRX) vs. iShares MSCI Australia ETF (EWA)

Noronex Ltd. Business Overview & Revenue Model

Company Description
Noronex Limited is primarily involved in the exploration of minerals. Their efforts specifically target the discovery of base metals, precious metals, and copper deposits. A key focus is the Witvlei project, situated in Namibia's Kalahari Copper B...

Noronex Ltd. Financial Statement Overview

Summary
Despite improving revenue off a low base, the company remains deeply loss-making with persistent negative operating profitability and ongoing cash burn. The main offset is a debt-free balance sheet, but shrinking equity and negative returns increase funding and dilution risk.
Income Statement
18
Very Negative
Balance Sheet
52
Neutral
Cash Flow
22
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue124.59K368.16K40.68K0.000.000.00
Gross Profit124.59K368.16K40.68K0.000.000.00
EBITDA-1.93M-1.08M-2.52M36.40K148.07K25.73K
Net Income-1.43M-3.13M-2.51M-3.35M-5.55M-2.15M
Balance Sheet
Total Assets2.44M2.20M3.81M3.32M5.05M5.72M
Cash, Cash Equivalents and Short-Term Investments1.14M1.01M913.58K393.75K2.11M3.01M
Total Debt0.000.000.000.000.000.00
Total Liabilities1.04M1.22M754.42K424.52K468.48K259.97K
Stockholders Equity1.37M951.15K3.02M2.85M4.36M5.11M
Cash Flow
Free Cash Flow-4.77M-3.68M-2.36M-3.12M-5.36M-2.06M
Operating Cash Flow-4.90M-3.68M-2.36M-3.12M-5.28M-1.80M
Investing Cash Flow87.53K-42.61K412.06K0.00-80.00K-703.93K
Financing Cash Flow5.33M3.78M2.47M1.42M4.46M4.02M

Noronex Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.01
Price Trends
50DMA
0.01
Negative
100DMA
0.01
Negative
200DMA
0.01
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
42.78
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NRX, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.78 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NRX.

Noronex Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
AU$199.60M4.83-118.27%-95.70%8.86%
51
Neutral
AU$219.67M-12.17-14.19%78.60%
44
Neutral
AU$162.04M-12.60-242.58%-79.69%
44
Neutral
AU$27.99M-10.55-7.21%85.19%
43
Neutral
AU$7.02M-4.35-123.30%62.32%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NRX
Noronex Ltd.
0.01
>-0.01
-8.33%
AU:CYM
Cyprium Metals Limited
0.37
0.11
43.97%
AU:CVV
Caravel Minerals Limited
0.27
0.11
68.75%
AU:REC
Recharge Metals Limited
0.02
0.01
140.00%
AU:AR1
Austral Resources Australia Limited
0.08
-0.08
-51.25%

Noronex Ltd. Corporate Events

Cumulus Wealth Exits Substantial Shareholding in Noronex
Jun 9, 2026
Noronex Limited has disclosed that Cumulus Wealth Pty Ltd has ceased to be a substantial shareholder in the company as of 5 June 2026, in line with Australian Corporations Act reporting requirements. The notice indicates that Cumulus Wealth’...
Noronex Files Final Director’s Interest Notice for Departing Board Member
May 1, 2026
Noronex Limited has disclosed that director Victor Rajasooriar ceased to be a director of the company on 1 May 2026, in line with its obligations under ASX listing rule 3.19A.3. The final director’s interest notice confirms he holds no Noron...
Noronex trims potential dilution as options and rights lapse
May 1, 2026
Noronex Ltd. has reported changes to its capital structure, notifying the market that certain options and performance rights on issue have lapsed. The update focuses on the cessation of these equity-linked instruments and does not outline any chan...
Noronex appoints Xcend as new share registry provider
Apr 9, 2026
Noronex Limited has appointed Xcend Pty Ltd as its new share registry provider, effective 13 April 2026, replacing Automic Registry Services. The change centralises shareholder administration through Xcend’s online investor portal, where sec...
Noronex clears new share issue for on-sale under Corporations Act exemption
Apr 2, 2026
Noronex Limited has issued 9,069,921 fully paid ordinary shares and notified the market that these securities qualify for on-sale without a disclosure document under section 708A(5) of the Corporations Act 2001. The company confirmed it is up to d...
Noronex Issues 20 Million Unquoted Options in Capital Management Move
Apr 2, 2026
Noronex Limited has notified the market of a new issue of unquoted equity securities, detailing the creation of 20,000,000 unquoted options exercisable at $0.024 and expiring on 23 November 2027. The options, issued on 2 April 2026 and not intende...
Noronex Issues 1 Million Shares for Geological Consulting Services
Apr 2, 2026
Noronex Ltd., listed on the ASX under ticker NRX, has issued additional ordinary fully paid shares in connection with its ongoing resource-focused activities that rely on geological consulting. The move underlines the company’s use of equity...
Noronex Seeks ASX Quotation for 1 Million Shares Issued for IR and PR Services
Apr 2, 2026
Noronex Limited has applied for quotation on the ASX of 1,000,000 new ordinary fully paid shares, issued on 2 April 2026 as consideration for investor and public relations services. The issuance, executed without a prior Appendix 3B due to the con...
Noronex seeks ASX quotation for 7.1 million new shares
Apr 2, 2026
Noronex Ltd has lodged an application with the ASX for quotation of 7,069,921 ordinary fully paid shares under code NRX, with an issue date of 2 April 2026. The securities form part of a previously announced transaction and, once quoted, will expa...
Noronex CEO Departs as Explorer Reaffirms Strategy and South32-Backed Programs
Mar 20, 2026
Noronex Limited has announced the resignation of Managing Director and CEO Victor Rajasooriar, who is leaving to lead Wiluna Mining Corporation, with the board and executive team assuming his responsibilities during the transition until a permanen...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 19, 2026